3.45 USD
↗ 0.93 (36.91%)AT CLOSE (11:59 AM EDT)
Medicinova, Inc.
MNOVNASDAQ • USD
3.45
↗ 0.00 (0.00%)
POST MARKET (AS OF 07:29 PM EDT)
Post Market
AS OF 07:29 PM EDT
3.45
↗ 0.00 (0.00%)
Market: OPEN
Medicinova, Inc. (MNOV) is currently trading at $3.45. Our models show a "Strong Buy" technical signal alongside a "Neutral" fundamental rating. Key drivers include a robust Altman Z-Score, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. Furthermore, MNOV is currently richly valued, trading at a premium to sector peers across key valuation metrics.
Technical & fundamental data as of Sep 17, 2026.
Open?$2.84
High?$3.90
Low?$2.83
Prev. Close?$2.52
Volume?7.4M
Avg. Volume?99.6K
VWAP?$3.44
Rel. Volume?74.15x
Bid / Ask
Bid?$2.88 × 100
Ask?$3.92 × 100
Spread?$1.04
Midpoint?$3.40
Valuation & Ratios
Market Cap?124.0M
Shares Out?49.2M
Float?40.3M
Float %?81.9%
P/E Ratio?N/A
P/B Ratio?3.33
EPS?-$0.22
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
MediciNova Inc is a biopharmaceutical company developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus on the United States (U.S.) market. It is currently focused on developing MN-166 (ibudilast) for neurological and other disorders such as progressive multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and prevention of acute respiratory distress syndrome (ARDS); and MN-001 (tipelukast) for fibrotic and other metabolic disorders such as nonalcoholic fatty liver disease (NAFLD), and hypertriglyceridemia.
Employees
6
Market Cap
124.0M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2006-12-07
Address
4275 EXECUTIVE SQUARE
LA JOLLA, CA 92037
Phone: 858-373-1500
LA JOLLA, CA 92037
Phone: 858-373-1500
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?23
Z-Score?100
Momentum?94
Short Sent.?46
Piotroski F-Score?3/9Weak
Altman Z-Score?7.91Safe
Confidence?48%Low
Short InterestHigh
Short % of Float?0.92%Low
Short Interest?369.7K
Days to Cover?7.7
Free Float40.3M
Avg Daily Volume48.0K
Settlement Date2026-08-31
Financial Health
Current Ratio?8.75Strong
Quick Ratio?8.75Strong
Cash Ratio?8.58Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score58/100
P/E?N/A▾
P/B?3.33FAIR▾
Peers100
S&P51
P/S?134.75HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-8.3CHEAP▾
S&P97
EV/Sales?107.14HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-28.8%WEAK▾
S&P6
ROA?-26.6%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-9123980
Enterprise Value?$98.6M
Fundamentals ratios updated end of day